# MT2004-30: Tomotherapy for Solid Tumors

> **NCT00623077** · PHASE1 · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 23 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Kidney Cancer
- Liver Cancer
- Retinoblastoma
- Sarcoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** busulfan
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** melphalan
- **DRUG:** thiotepa
- **PROCEDURE:** stem cell transplantation
- **RADIATION:** tomotherapy
- **RADIATION:** total marrow irradiation
- **DRUG:** Mesna
- **RADIATION:** Whole lung radiation

## Key facts

- **NCT ID:** NCT00623077
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-08
- **Primary completion:** 2012-07
- **Final completion:** 2016-10
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Replaced by another study
- **Last updated:** 2017-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00623077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00623077, "MT2004-30: Tomotherapy for Solid Tumors". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00623077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*